References
- WHO. World health organization. Control of chagas disease. Tech Rep Ser 2002; 905: 1–109
- Moncayo A. Progress towards interruption of transmission of chagas disease. Mem Inst Oswaldo Cruz 1999; 94: 401–404
- Urbina JA. Parasitological cure of Chagas disease: Is it possible? Is it relevant?. Mem Inst Oswaldo Cruz 1999; 94: 349–355
- Tsuhako MH, Alves MJ, Colli W, Filardi LS, Brener Z, Augusto O. Comparative studies of drug resistant and susceptible strains of Trypanosoma cruzi. Comp Biochem Physiol C 1991; 99: 317–321
- Chena MA, Elizondo-Jimenez S, Rodríguez-Páez L, Nogueda-Torres B, Baeza-Ramírez I, Wong-Ramírez C. Trypanosoma cruzi: Inhibition of α-hydroxyacid dehydrogenase isozyme II by N-allyl and N-propyl oxamates and their effects on intact epimastigotes. Mem Inst Oswaldo Cruz 2004; 99: 831–837
- Opperdoes FR. Biochemical peculiarities of trypanosomes african and south american. Br Med Bull 1985; 41: 130–136
- Bakker BM, Westerhoff HV, Opperdoes FR, Michels PAM. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Mol Biochem Pharmacol 2000; 106: 1–10
- Bronfen E, Rocha FSA, Machado GBN. Isolamento de amostras do trypanosoma cruzi por genodiagnostico e hemoculture de pacientes na fase cronica da doenca de chagas. Mem Inst Oswaldo Cruz 1989; 84: 234–240
- Chiairi E, Diaz JCP, Lana M, Chiari CA. Haemocultures for the parasitological diagnosis of human chronic chagas disease. Rev Soc Bras Med Trop 1989; 22: 19–23
- Montamat EE, Arauso SS, Blanco A. Subcellular localization of leucine aminotranferase and α-hydroxyacid dehydrogenase in Trypanosoma cruzi. Mol Biochem Parasitol 1987; 22: 185–193
- Barr JC, Rose D, Jaines JM. Activity of lytic peptides against intracellular trypanosoma cruzi amastigotes in vitro and parasitaemia in mice. J Parasitol 1995; 81: 974–978
- Urbina JA, Payares G, Contreras LM, Liendo A, Sanoja C, Molina J, Piras M, Piras R, Perez N, Wincker P, Luebenberg D. Antiproliferative effects and mechanism of action of SCH56592 against Trypanosoma cruzi: In vitro and in vivo studies. Antimicrob Agents Chemother 1998; 42: 1771–1777
- Chena MA, Elizondo S, Rodríguez-Páez L, Nogueda B, Baeza I, Wong C. Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains. J Enz Inhib Med Chem 2005; 20: 189–197
- Filardi LS, Brener Z. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Mem Inst Oswaldo Cruz 1984; 79: 221–225
- NIH. National Institute of Health. 1985; 85–123, Guide for the care and use of laboratory animals. Office of science and health report, DRR/NIH DHEW publication.
- Verlinde CL, Hanaert V, Blonski C, Wilson M, Perie JJ, Forthergill-Gilmore LA, Opperdoes FR, Gelb MH, Hol WG, Michels PA. Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Update 2001; 41: 130–136
- Coronel CE, Rovai LE, Gerez de Burgos NM, Burgos C, Blanco A. Properties of α-hydroxyacid dehydrogenase isozymes from Trypanosoma cruzi. Mol Biochem Parasitol 1981; 4: 29–38
- Gerez de Burgos NM, Burgos C, Blanco A, Paulone I, Segura EL. Actividad de alfa-hidroxiácido deshidrogenasa en trypanosoma cruzi. Acta Physiol Latinoam 1976; 26: 10–19
- Gerez de Burgos NM, Burgos C, Montamat EE, Rovai LE, Blanco A. Inhibition by gossypol of oxidoreductases from Trypanosoma cruzi. Biochem Pharmacol 1984; 33: 955–959
- Elizondo S, Chena MA, Rodríguez-Páez L, Nogueda B, Baeza I, Wong C. Inhibition of Trypanosoma cruzi α-hydroxyacid dehydrogenase isozyme II by N-isopropyl oxamate and its effect on intact epimastigotes. J Enz Inhib Med Chem 2003; 18: 265–271
- Atwood JA, Weatherly DB, Minning TA, Bundy B, Cavola F, Opperdoes FR, Orlando R, Tarleton RL. The Trypanosoma cruzi proteome. Science 2005; 309: 473–476
- Aldunate J, Repetto Y, Letelier ME, Morello A. The carboxyl esterases of Trypanosoma cruzi epimastigotes. Comp Biochem Physiol 1987; 86: 67–71
- Repetto Y, Aldunate J, Morello A. Trypanosoma cruzi: Carboxylesterase activity in intact epimastigotes. Comp Biochem Physiol B 1983; 76: 61–64
- Docampo R. Sensitivity of parasites to free radicals damage by parasitic drugs. Chem Biol Interact 1990; 73: 1–27
- Brener Z. Recent advances in the chemotherapy of chagas disease. Mem Inst Oswaldo Cruz 1984; 79: 149–155